Nexalin Technology, Inc. - Common Stock (NXL)
3.5800
+0.4700 (15.11%)
Nexalin Technology, Inc. is a publicly traded company focused on the development and commercialization of innovative therapeutic technologies designed to improve mental health and wellness
The company specializes in non-invasive neurostimulation therapies that target various mental health conditions, offering potential alternative treatment options. By integrating advanced technology with a commitment to research and development, Nexalin aims to enhance the quality of life for individuals seeking effective solutions to manage their mental health challenges.